Eggehard Holler
Corporate Officer/Principal en University of Regensburg .
Perfil
Eggehard Holler is the founder of Arrogene, Inc. which was founded in 2006.
He held the title of Director from 2006 to 2013.
Currently, he is a Professor at the University of Regensburg, a position he has held since 1972.
Dr. Holler earned a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Cargos activos de Eggehard Holler
| Empresas | Cargo | Inicio |
|---|---|---|
| University of Regensburg | Corporate Officer/Principal | 01/01/1972 |
Antiguos cargos conocidos de Eggehard Holler.
| Empresas | Cargo | Fin |
|---|---|---|
Arrogene, Inc.
 Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Fundador | - |
Formación de Eggehard Holler.
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Arrogene, Inc.
Arrogene, Inc. Pharmaceuticals: MajorHealth Technology Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Eggehard Holler
